Facebook Pixel Code
About Sickkids
About SickKids

Damien Noone, MB BCh BAO, MSc

The Hospital for Sick Children
Staff Nephrologist

Director, Nephrology Training Program

University of Toronto
Assistant Professor
Faculty of Medicine, Department of Paediatrics

Phone: 416-813-7654 x 204486
Fax: 416-813-6271
Email: damien.noone@sickkids.ca

Brief Biography

Dr. Damien Noone joined the Division of Nephrology at The Hospital for Sick Children in 2014, as a Staff Physician and Assistant Professor of Paediatrics, Faculty of Medicine, University of Toronto. Dr. Noone attended medical school at the National University of Ireland in Galway and completed his specialty training in General Paediatrics also in Ireland. He began his training in Paediatric Nephrology there, while working at Our Lady’s Children’s Hospital, Crumlin and at the National Paediatric Renal Transplant and Haemodialysis Unit, at Temple Street Children’s University Hospital in Dublin. He furthered his training in Paediatric Nephrology at Great Ormond Street Hospital for Children, National Health Services Foundation Trust from 2010 to 2011, after which he came to Toronto and completed a fellowship in Paediatric Nephrology at The Hospital for Sick Children, from 2011 to 2014. He completed a Master’s degree at The University of Toronto studying complement and endothelial cell biology.


2013-14    Edward Christie Stevens Fellowship in Medicine, Postgraduate Research Medical Education Research Award, University of Toronto - $9,650 CDN

2013-14    HSBC Bank Canada Student Bursary, Restracomp - $20,000 CDN

Clinical Interests

  • Staff physician in the Division of Nephrology (The Hospital for Sick Children)
  • Dr. Noone co-developed the combined Rheumatology/Nephrology Systemic Vasculitis Clinic and participates in the glomerular disorders and renal genetic disorders focus groups within the Division of Nephrology.
  • Dr. Noone is one of a core group of nephrologists providing care to patients on chronic dialysis.

Academic Background

2015        MSc, Institute of Medical Science, University of Toronto

2009        Postgraduate Diploma in Medical Science (Health Informatics), NUI, Galway, Ireland

2006        MRCPI, Member of The Royal College of Physicians of Ireland – Paediatrics, RCPI. Dublin, Ireland

2002        MB BCh BAO, National University of Ireland (NUI), Galway, Ireland

Research Interests

• Clinical translational research
• Complement-mediated glomerular diseases
• Renal Vasculitis especially ANCA-associated vasculitides
• Vascular and endothelial cell dysfunction


  1. Noone DG, Twilt M, Hayes W, Thorner PS, Benseler S, Laxer RM, Parekh RS, Hebert D. The New Histopathologic Classification of ANCA-Associated GN and Its Association with Renal Outcomes in Childhood. Clin J Am Soc Nephrol 9:, 2014. doi: 10.2215/CJN.01210214
  2. Kim JJ, McCulloch M, Marks SD, Waters A, Noone D. The Clinical Spectrum of Hemolytic Uremic Syndrome Secondary to Complement Factor H Autoantibodies. Clinical Nephrology. 2013. DOI:10.5414/CN107777
  3. Noone D, Waters A, Geary DF, Kirschfink M, Zipfel PF, Licht C. Successful Treatment of DEAP- HUS with Eculizumab. Pediatr Nephrol. 2013; DOI:10.1007/s00467-013-2654-x
  4. Noone D, Licht, C. Chronic Kidney Disease - A New Look at Pathogenetic Mechanisms and Treatment Options. Pediatr Nephrol. 2013.
  5. Noone DG, Marks SD. Hyperuricemia is associated with hypertension, obesity, and albuminuria in children with chronic kidney disease. The Journal of Pediatrics. 2013;162:128-32.
  6. Noone D, Licht C. An update on the pathomechanisms and future therapies of Alport syndrome. Pediatr Nephrol. 2012.
  7. Noone D, Al-Matrafi J, Tinckam K, Licht C. Antibody mediated rejection associated with complement factor h-related protein 3/1 deficiency successfully treated with eculizumab. American Journal of Transplantation. 2012;12:2546-53.
  8. Noone D, Kieran E, Molloy EJ. Serum magnesium in the first week of life in extremely low birth weight infants. Neonatology. 2012;101:274-7.
  9. McDowell DT, Noone D, Tareen F, Waldron M, Quinn F. Urinary incontinence in children: botulinum toxin is a safe and effective treatment option. Pediatr Surg Int. 2012;28:315-20.
  10. 0.  Noone D, van der Spek N, Waldron M. A consultant paediatrician led and public health nurse (PHN) provided Community Enuresis Clinic as a model of care. Ir Med J. 2011;104:44-6.